Peeking into the black box of privacy - Biobank participants on the importance of recognition

Norsk Epidemiologi

Volumn 21, Issue 2, 2012, Pages 269-276

  Ursin, Lars Øystein ^a   Steinsbekk, Kristin Solum ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; COMPUTER SECURITY; CONFIDENTIALITY; FREEDOM; HUMAN; MEDICAL ETHICS; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; PRIVACY; PROFESSIONALISM; RESEARCH ETHICS; RESEARCH SUBJECT; SENSITIVITY ANALYSIS; SOCIAL ATTITUDE; TRUST;

EID: 84863006363     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i2.1502     Document Type: Article

References (43)

1. Bialobrzeski A, Ried J, Dabrock P. Privacy revisited? Old ideals, new realities, and their impact on biobank regimes. Poiesis Prax 2011; 8: 9-24.
2. Heeney C, et al. Assessing the privacy risks of data sharing in genomics. Public Health Genomics 2011; 14 (1): 17-25.
3. Lowrance WW, Collins FS. ETHICS identifiability in genomic research. Science 2007; 600: 602.
4. Homer N, et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet 2008; 4 (8): e1000167.
5. McGuire AL, Gibbs RA. No longer de-identified. Science 2006; 312 (5772): 370.
6. Austin LM, Lemmens T. Privacy, consent, and governance. New challenges for biobanks: Ethics, law and governance, 2009.
7. Lunshof JE, et al. From genetic privacy to open consent. Nature Rev Genet 2008; 9 (5): 406-410.
8. Solove DJ, Schwartz PM. Privacy, information, and technology. Aspen Law & Business, 2008.
9. Hansson MG. The private sphere: an emotional territory and its agent. Springer Verlag, 2007.
10. Schoeman FD. Philosophical dimensions of privacy: An anthology. Cambridge University Press, 1984.
11. Rössler B, Glasgow RDV. The value of privacy. Polity Press, 2005.
12. Rothstein MA. Genetic secrets. Yale University Press, 1997.
13. Laurie GT. Genetic privacy: a challenge to medico-legal norms. Cambridge University Press, 2002.
14. Ursin L. Biobank research and the right to privacy. Theor Med Bioeth 2008; 29 (4): 267-285.
15. Ursin L. Privacy and property in the biobank context. HEC Forum 2010; 22 (3): 211-224.
16. Kaufman DJ, et al. Public opinion about the importance of privacy in biobank research. Am J Hum Genet 2009; 85 (5): 643-654.
17. Manson NC. Rethinking informed consent in bioethics. Cambridge University Press, 2007.
18. Gaskell G, Gottweis H. Biobanks need publicity. Nature 2011; 471: 159-160.
19. Morgan DL. Focus groups as qualitative research. Sage Publications, 1997.
20. Massey OT. A proposed model for the analysis and interpretation of focus groups in evaluation research. Eval Program Plann 2011; 34 (1): 21-28.
21. Schweda M, Schicktanz S. Public ideas and values concerning the commercialization of organ donation in four European countries. Soc Sci Med 2009; 68 (6): 1129-1136.
22. Bohnsack R. Rekonstruktive Sozialforschung: Einführung in qualitative Methoden. Vol. 8242. 2007: Budrich.
23. Levitt M, Weldon S. A well placed trust?: Public perceptions of the governance of DNA databases. Critical Public Health 2005; 15 (4): 311-321.
24. The HUNT study-a longitudinal population health study in Norway. http://www.ntnu.edu/hunt.
25. Holmen J, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13 (1): 19-32.
26. Holmen J, et al. Attitudes to genetic epidemiology-illustrated by question for re-consent to 61,426 participants at HUNT. Norsk Epidemiologi 2004; 14: 27-31.
27. Johnsson L, et al. Hypothetical and factual willingness to participate in biobank research. Eur J Hum Genet 2010; 18: 1261-1264.
28. Steinsbekk KS, et al. We're not in it for the money-lay people's moral intuitions on commercial use of 'their' biobank. Medicine, Health Care and Philosophy 2011: 1-12.
29. Skolbekken JA, et al. Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context. Critical Public Health 2005; 15 (4): 335-347.
30. Haddow G, et al. Tackling community concerns about commercialisation and genetic research: a modest interdisciplinary proposal. Soc Sci Med 2007; 64 (2): 272-282.
31. Krueger RA. Focus group kit. Vol. 6, Analyzing & reporting focus group results. Sage publications, 1998.
32. Krueger RA. Moderating focus groups. Sage Publications, 1998.
33. Mayring, Qualitative content analysis. Citeseer, 2000.
34. Malterud K. Kvalitative metoder i medisinsk forskning, 2. utg. Oslo: Universitetsforlaget, 2003.
35. Kamberelis G, Dimitriadis G. Focus groups: Strategic articulations of pedagogy, politics, and inquiry. The Sage handbook of qualitative research, 2005; 3: 887-907.
36. Solove D. Understanding privacy. Harvard University Press, May 2008.
37. Solove DJ. Conceptualizing privacy. California Law Review 2002: 1087-1155.
38. Wittgenstein L, Hacker PMS, Schulte J. Philosophical investigations. John Wiley and Sons, 2009.
39. Hofmann B. Broadening consent-and diluting ethics? J Med Ethics 2009; 35 (2): 125.
40. Caulfield T, Kayet J. Broad consent in biobanking: reflections on seemingly insurmountable dilemmas. Med law Int 2009; 10 (2): 85-100.
41. Sheehan M. Can broad consent be informed consent? Public Health Ethics 2011; 4: 226-235.
42. Simon CM, et al. Active choice but not too active: Public perceptions on biobank consent models; Genet Med 2011; 13 (9): 821-831.
43. Antonsen S. Motivasjon for deltakelse i helseundersøkelser. Norsk Epidemiologi 2009; 15 (1): 99-109.